- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
MBI taps Venkatadri as new president
MBI has named Bobba Venkatadri as president and COO, the San Diegoultrasound contrast developer announced last week. Venkatadritakes the place of Vincent Frank, who passed away in August aftera lengthy illness. Venkatadri comes to MBI from monoclonal
MBI has named Bobba Venkatadri as president and COO, the San Diegoultrasound contrast developer announced last week. Venkatadritakes the place of Vincent Frank, who passed away in August aftera lengthy illness.
Venkatadri comes to MBI from monoclonal antibody developerCentocor, where he served as executive vice president of the company'spharmaceutical division. He was instrumental in restructuringCentocor and in building strategic alliances and managing R&D,according to MBI.
In other news, MBI earlier this month said the Federal TradeCommission has cleared its new distribution and investment agreementwith Mallinckrodt Medical (SCAN 9/13/95).
Emerging Perspectives on PSMA PET Radiotracers: An Interview with Kenneth J. Pienta, MD
April 24th 2024In a recent interview, Kenneth J. Pienta, M.D., discussed the impact of piflufolastat F18, current directions in research with other PSMA-targeted radiotracers and future possibilities for the role of PSMA PET in the imaging paradigm for prostate cancer.
Could a Newly FDA-Cleared C-Arm Device Bolster Efficiency for Interventional Radiologists?
April 22nd 2024In addition to advanced imaging quality and dose efficiency, the Philips Zenition 30 mobile C-arm device emphasizes personalized user profiles and automated customization to help reduce procedure time.
